✦ LIBER ✦

Regulatory issues in cellular therapies

✍ Scribed by Adrian P. Gee

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 85 KB
Volume: 85
Category: Article
ISSN: 0730-2312
DOI: 10.1002/jcb.10028

No coin nor oath required. For personal study only.

✦ Synopsis

Cellular and gene therapies offer considerable promise as new treatment modalities. The Food and Drug Administration has been developing strategies to regulate these rapidly evolving fields in a manner that sustains progress and also ensures minimization of potential risks. The death of a patient on a gene therapy study highlighted a number of potential problems that have galvanized the agency to examine their strategy and to review current regulations for gene therapy. Meanwhile, a unified regulatory approach is emerging for cell-based therapies. This stratifies the level of regulation based upon the potential risk to the donor of the cells and the recipient. In this article the history and status of regulation of cellular therapy is briefly reviewed.

📜 SIMILAR VOLUMES

Gene therapy in germany and in europe: r

Gene therapy in germany and in europe: regulatory issues

✍ Klaus Cichutek; Ines Krämer 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB

Issues in antiemetic therapy

✍ Barry R. Goldspiel; Gregory A. Curt 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

Apoptosis and cellular vitality: Issues

Apoptosis and cellular vitality: Issues in osteoarthritic cartilage degeneration

✍ T. Aigner; H. A. Kim 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

Interactions between Ras and Raf: Key re

Interactions between Ras and Raf: Key regulatory proteins in cellular transformation

✍ Mark Marshall 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 727 KB

## Abstract Ras proteins function during cell growth and development as essential, plasma membrane‐bound signaling proteins. Current evidence suggests that Ras is part of a signal transduction chain extending from extracellular signals to transcriptional regulation in the nucleus. Growth factor and

Potential for creatine and other therapi

Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders

✍ Mark A. Tarnopolsky; M. Flint Beal 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

Practical issues in the realization of q

Practical issues in the realization of quantum-dot cellular automata

✍ Gary H. Bernstein; Greg Bazan; Minhan Chen; Craig S. Lent; James L. Merz; Alexei 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Several practical issues in the development and operation of quantum-dot cellular automata (QCA) cells and systems are discussed. The need for adiabatic clocking of QCA systems and modeling of electrostatic confinement of quantum dots are presented. Experimental data on dot coupling and applications